Two-year efficacy and safety in abatacept-treated patients with RA who received continuous therapy or switched from infliximab to abatacept: the ATTEST trial

Authors
Category Primary study
JournalAnn Rheum Dis
Year 2009
This article has no abstract
Epistemonikos ID: f3ca80067069b1b13fff0e951ba678b258a71c1c
First added on: Nov 01, 2017